Biglycan (December 2011) Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University 14 years ago Research & Clinical Trial Webinars,Webinars You may also like 51:49 Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study Expansion 1 year ago Research & Clinical Trial Webinars,Webinars sgt-003,solid biosciences 56:19 Webinar: Exploring Muscle Regeneration – A New Approach with Satellos 1 year ago Research & Clinical Trial Webinars,Webinars 44:01 World Muscle Society 2024: CIFFREO Data Discussion with Pfizer 1 year ago Research & Clinical Trial Webinars,Webinars fordadistrogene movaparvovec,pfizer 59:49 Webinar: SHIELD DMD – A Bone Health Study in Duchenne 1 year ago Research & Clinical Trial Webinars,Webinars satralizumab 43:40 Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy 1 year ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 51:42 Webinar: Overview of DUVYZAT and Access Resources (September 2024) 1 year ago Research & Clinical Trial Webinars,Webinars 1:04:54 Webinar: Advocating for A Successful School Year (September 2024) 1 year ago Care Webinars,Webinars 1:01:24 Webinar: PPMD Advocacy – Raising Our Voices in 2024 and Beyond [Sep 2024] 1 year ago Webinars «123456…28»Page 4 of 28